November 21, 2013 / 7:16 AM / in 4 years

BRIEF-Otsuka, Lundbeck's Abilify Maintena approved in EU

COPENHAGEN, Nov 21 (Reuters) - Danish pharmaceutical company H. Lundbeck A/S said on Thursday: * Once-monthly Abilify Maintena, which is developed in partnership with Japan’s Otsuka , has been approved by the European Commision for maintenance treatment of schizophrenia in adult patients stabilized with oral aripiprazole

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below